July 19-21 2016 | Boston

As the critical bedrock for the successful development of more effective and personalised cancer therapies, the 4th Annual Tumor Models Boston Summit is back with even more preclinical and clinical case studies to help you enhance your preclinical predictability studies, biomarker validation and translational decision making to achieve rapid clinical and regulatory success.

With the immunotherapy race well and truly on, alongside a hot pursuit to find the most synergistic combination therapies, humanized, syngeneic and patient derived cancer models will be scrutinized to enhance their use and effective translate preclinical knowledge into clinical utility.

"Excellent Tumor Models meeting that was very well attended. Great program, speakers and panelists, which made for productive discussions, networking and exchange of ideas."

- Genentech

Tumor Model Gif